In recent years, CDCA5 was reported to function as a tumor promoter in various tumors, including bladder cancer, hepatocellular carcinoma [12, 13], gastric cancer [14, 15] and esophageal squamous cell carcinoma [16], as well as the breast cancer [17–19]. Here, CDCA5 is linked to gastric cancer.